{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T01:13:54Z","timestamp":1788484434119,"version":"build-2803163510"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"vor","delay-in-days":79,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Research Fund Project for Science and Technology Development of Nanjing Medical University","award":["NMUB20240044"],"award-info":[{"award-number":["NMUB20240044"]}]},{"name":"the Changzhou Medical Center","award":["CMCB202401"],"award-info":[{"award-number":["CMCB202401"]}]},{"name":"the Jiangsu Provincial Health Commission General Project","award":["MQ2024036"],"award-info":[{"award-number":["MQ2024036"]}]},{"name":"the Excellent Post-doctoral Program of Jiangsu Province","award":["2022ZB820"],"award-info":[{"award-number":["2022ZB820"]}]},{"name":"the Top Talent of Changzhou ''The 14th Five-Year Plan'' High-Level Health Talents Training Project","award":["2022CZBJ065"],"award-info":[{"award-number":["2022CZBJ065"]}]},{"name":"the Post-doctoral Foundation of China","award":["2022M720543"],"award-info":[{"award-number":["2022M720543"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biol Direct"],"DOI":"10.1186\/s13062-026-00872-7","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:46:18Z","timestamp":1781703978000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoxia and lactate metabolism-related gene COL5A3 promotes triple negative breast cancer progression via DDR1\/FAK\/PI3K\/AKT pathway"],"prefix":"10.1186","volume":"21","author":[{"given":"Quan-feng","family":"Shao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-ying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-xian","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,17]]},"reference":[{"issue":"6","key":"872_CR1","first-page":"524","volume":"72","author":"AN Giaquinto","year":"2022","unstructured":"Giaquinto AN, Sung H, Miller KD, Kramer JL, Newman LA, Minihan A, et al. Breast Cancer Stat 2022 CA Cancer J Clin. 2022;72(6):524\u201341.","journal-title":"Breast Cancer Stat 2022 CA Cancer J Clin"},{"issue":"4","key":"872_CR2","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.3390\/jcm12041524","volume":"12","author":"Jieun Lee","year":"2023","unstructured":"Jieun Lee. Current Treatment Landscape for Early Triple-Negative Breast Cancer (TNBC). J Clin Med. 2023;12(4):1524.","journal-title":"J Clin Med"},{"issue":"3","key":"872_CR3","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","volume":"35","author":"YZ Jiang","year":"2019","unstructured":"Jiang YZ, Ma D, Suo C, Shi J, Xue M, Hu X, et al. Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies. Cancer Cell. 2019;35(3):428\u2013e4405.","journal-title":"Cancer Cell"},{"issue":"1","key":"872_CR4","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"key":"872_CR5","first-page":"39","volume":"8","author":"C Li","year":"2025","unstructured":"Li C, Liu Z, Kong D, Li Z, Li L. Lactylation: a novel driver of drug resistance in the tumor microenvironment. Cancer Drug Resist. 2025;8:39.","journal-title":"Cancer Drug Resist"},{"key":"872_CR6","doi-asserted-by":"publisher","first-page":"217156","DOI":"10.1016\/j.canlet.2024.217156","volume":"600","author":"Z Kooshan","year":"2024","unstructured":"Kooshan Z, C\u00e1rdenas-Piedra L, Clements J, Batra J. Glycolysis, the sweet appetite of the tumor microenvironment. Cancer Lett. 2024;600:217156.","journal-title":"Cancer Lett"},{"key":"872_CR7","doi-asserted-by":"publisher","first-page":"1353787","DOI":"10.3389\/fimmu.2024.1353787","volume":"15","author":"A Nicolini","year":"2024","unstructured":"Nicolini A, Ferrari P. Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy. Front Immunol. 2024;15:1353787.","journal-title":"Front Immunol"},{"issue":"1","key":"872_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13058-025-02039-0","volume":"27","author":"X Ma","year":"2025","unstructured":"Ma X, Zhang B, Yin X, Yang S, Lin Z, Yang Y, et al. CPT1A\/HIF-1\u03b1 positive feedback loop induced fatty acid oxidation metabolic pathway contributes to the L-ascorbic acid-driven angiogenesis in breast cancer. Breast Cancer Res. 2025;27(1):74.","journal-title":"Breast Cancer Res"},{"issue":"43","key":"872_CR9","doi-asserted-by":"publisher","first-page":"e35493","DOI":"10.1097\/MD.0000000000035493","volume":"102","author":"L Liu","year":"2023","unstructured":"Liu L, Bai J, Hu L, Jiang D. Hypoxia-mediated activation of hypoxia-inducible factor-1\u03b1 in triple-negative breast cancer: A review. Med (Baltim). 2023;102(43):e35493.","journal-title":"Med (Baltim)"},{"issue":"2","key":"872_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3390\/proteomes13020025","volume":"13","author":"D Perico","year":"2025","unstructured":"Perico D, Mauri P. Deciphering Radiotherapy Resistance: A Proteomic Perspective. Proteomes. 2025;13(2):25.","journal-title":"Proteomes"},{"key":"872_CR11","doi-asserted-by":"publisher","first-page":"1199105","DOI":"10.3389\/fonc.2023.1199105","volume":"13","author":"N Srivastava","year":"2023","unstructured":"Srivastava N, Usmani SS, Subbarayan R, Saini R, Pandey PK. Hypoxia: syndicating triple negative breast cancer against various therapeutic regimens. Front Oncol. 2023;13:1199105.","journal-title":"Front Oncol"},{"issue":"6","key":"872_CR12","doi-asserted-by":"publisher","first-page":"3635","DOI":"10.1097\/MS9.0000000000003334","volume":"87","author":"EI Obeagu","year":"2025","unstructured":"Obeagu EI. Oxygen deprivation in breast cancer: mechanisms, pathways, and implications. Ann Med Surg (Lond). 2025;87(6):3635\u201359.","journal-title":"Ann Med Surg (Lond)"},{"issue":"1","key":"872_CR13","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41392-024-02082-x","volume":"10","author":"J Chen","year":"2025","unstructured":"Chen J, Huang Z, Chen Y, Tian H, Chai P, Shen Y, et al. Lactate and lactylation in cancer. Signal Transduct Target Ther. 2025;10(1):38.","journal-title":"Signal Transduct Target Ther"},{"issue":"12","key":"872_CR14","doi-asserted-by":"publisher","first-page":"5583","DOI":"10.3390\/ijms26125583","volume":"26","author":"S Tan","year":"2025","unstructured":"Tan S, Zhou F, Wu X. Lactate-Mediated Crosstalk Between Tumor Cells and Cancer-Associated Fibroblasts: Mechanisms and Therapeutic Opportunities. Int J Mol Sci. 2025;26(12):5583.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"872_CR15","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.3390\/biom14121646","volume":"14","author":"ZN Hao","year":"2024","unstructured":"Hao ZN, Tan XP, Zhang Q, Li J, Xia R, Ma Z. Lactate and Lactylation: Dual Regulators of T-Cell-Mediated Tumor Immunity and Immunotherapy. Biomolecules. 2024;14(12):1646.","journal-title":"Biomolecules"},{"key":"872_CR16","doi-asserted-by":"publisher","first-page":"1573039","DOI":"10.3389\/fimmu.2025.1573039","volume":"16","author":"X Jin","year":"2025","unstructured":"Jin X, Zhang N, Yan T, Wei J, Hao L, Sun C, et al. Lactate-mediated metabolic reprogramming of tumor-associated macrophages: implications for tumor progression and therapeutic potential. Front Immunol. 2025;16:1573039.","journal-title":"Front Immunol"},{"issue":"9","key":"872_CR17","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s12032-025-02940-w","volume":"42","author":"F Ghadyani","year":"2025","unstructured":"Ghadyani F, Zandi P, Ghafouri-Fard S. Histone lactylation: a new target for overcoming immune evasion and therapy resistance. Med Oncol. 2025;42(9):399.","journal-title":"Med Oncol"},{"key":"872_CR18","doi-asserted-by":"publisher","first-page":"102875","DOI":"10.1016\/j.arr.2025.102875","volume":"112","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Luo B, Sun X, Nagashima H, Wu Y, Liang G, et al. Non-histone lysine lactylation: Emerging roles in tumor biology and therapeutic implications. Ageing Res Rev. 2025;112:102875.","journal-title":"Ageing Res Rev"},{"key":"872_CR19","doi-asserted-by":"publisher","first-page":"111468","DOI":"10.1016\/j.cellsig.2024.111468","volume":"124","author":"J Li","year":"2024","unstructured":"Li J, Chen Z, Jin M, Gu X, Wang Y, Huang G, et al. Histone H4K12 lactylation promotes malignancy progression in triple-negative breast cancer through SLFN5 downregulation. Cell Signal. 2024;124:111468.","journal-title":"Cell Signal"},{"issue":"1","key":"872_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41419-025-07580-6","volume":"16","author":"W Qin","year":"2025","unstructured":"Qin W, Chen B, Li X, Zhao W, Wang L, Zhang N, et al. Cancer-associated fibroblasts secrete CSF3 to promote TNBC progression via enhancing PGM2L1-dependent glycolysis reprogramming. Cell Death Dis. 2025;16(1):249.","journal-title":"Cell Death Dis"},{"key":"872_CR21","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.omtn.2023.07.010","volume":"33","author":"X Yi","year":"2023","unstructured":"Yi X, Li J, Zheng X, Xu H, Liao D, Zhang T, et al. Construction of PANoptosis signature: novel target discovery for prostate cancer immunotherapy. Mol Ther Nucleic Acids. 2023;33:376\u201390.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"7","key":"872_CR22","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1016\/j.cell.2017.05.046","volume":"169","author":"Cancer Genome Atlas Research Network","year":"2017","unstructured":"Cancer Genome Atlas Research Network. Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell. 2017;169(7):1327\u201341.","journal-title":"Cell"},{"issue":"3","key":"872_CR23","first-page":"100141","volume":"2","author":"T Wu","year":"2021","unstructured":"Wu T, Hu E, Xu S, Chen M, Guo P, Dai Z, et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data. Innov (Camb). 2021;2(3):100141.","journal-title":"Innov (Camb)"},{"issue":"10","key":"872_CR24","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1002\/ijc.29154","volume":"135","author":"W Koh Minsoo","year":"2014","unstructured":"Koh Minsoo W, Yunjung, Valiathan Rajeshwari R, Jung Hae Yoen PS, Yeon KY, Nyun, et al. Discoidin domain receptor 1 is a novel transcriptional target of ZEB1 in breast epithelial cells undergoing H-Ras-induced epithelial to mesenchymal transition. Int J Cancer. 2014;135(10):2399\u2013408. https:\/\/doi.org\/10.1002\/ijc.29154.","journal-title":"Int J Cancer"},{"issue":"7886","key":"872_CR25","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/s41586-021-04057-2","volume":"599","author":"X Sun","year":"2021","unstructured":"Sun X, Wu B, Chiang HC, Deng H, Zhang X, Xiong W, et al. Tumour DDR1 promotes collagen fibre alignment to instigate immune exclusion. Nature. 2021;599(7886):673\u20138. https:\/\/doi.org\/10.1038\/s41586-021-04057-2.","journal-title":"Nature"},{"issue":"5","key":"872_CR26","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.4149\/neo_2022_220316N289","volume":"69","author":"Q Han","year":"2022","unstructured":"Han Q, Xiao F, Ma L, Zhou J, Wang L, Cheng H, et al. DDR1 promotes migration and invasion of breast cancer by modulating the Src-FAK signaling. Neoplasma. 2022;69(5):1154\u201364. https:\/\/doi.org\/10.4149\/neo_2022_220316N289.","journal-title":"Neoplasma"},{"key":"872_CR27","doi-asserted-by":"publisher","first-page":"1405491","DOI":"10.3389\/fonc.2024.1405491","volume":"14","author":"N Xiong","year":"2024","unstructured":"Xiong N, Wu H, Yu Z. Advancements and challenges in triple-negative breast cancer: a comprehensive review of therapeutic and diagnostic strategies. Front Oncol. 2024;14:1405491.","journal-title":"Front Oncol"},{"issue":"1","key":"872_CR28","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41420-025-02682-8","volume":"11","author":"L Liu","year":"2025","unstructured":"Liu L, Wu D, Qian Z, Jiang Y, You Y, Wang Y, et al. Empowering hypoxia to convert cold tumors into hot tumors for breast cancer immunotherapy. Cell Death Discov. 2025;11(1):381.","journal-title":"Cell Death Discov"},{"key":"872_CR29","doi-asserted-by":"publisher","first-page":"1060495","DOI":"10.3389\/fonc.2022.1060495","volume":"12","author":"S Liu","year":"2023","unstructured":"Liu S, Li Y, Yuan M, Song Q, Liu M. Correlation between the Warburg effect and progression of triple-negative breast cancer. Front Oncol. 2023;12:1060495.","journal-title":"Front Oncol"},{"key":"872_CR30","doi-asserted-by":"publisher","first-page":"101248","DOI":"10.1016\/j.drup.2025.101248","volume":"81","author":"Y Sun","year":"2025","unstructured":"Sun Y, Wang H, Cui Z, Yu T, Song Y, Gao H, et al. Lactylation in cancer progression and drug resistance. Drug Resist Updat. 2025;81:101248.","journal-title":"Drug Resist Updat"},{"key":"872_CR31","doi-asserted-by":"publisher","first-page":"896532","DOI":"10.3389\/fphar.2022.896532","volume":"13","author":"G Kasuya","year":"2022","unstructured":"Kasuya G, Nureki O. Recent Advances in the Structural Biology of the Volume-Regulated Anion Channel LRRC8. Front Pharmacol. 2022;13:896532.","journal-title":"Front Pharmacol"},{"issue":"10","key":"872_CR32","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1158\/2767-9764.CRC-22-0208","volume":"2","author":"CA Widmer","year":"2022","unstructured":"Widmer CA, Klebic I, Domanitskaya N, Decollogny M, Howald D, Siffert M, et al. Loss of the volume-regulated anion channel components LRRC8A and LRRC8D limits platinum drug efficacy. Cancer Res Commun. 2022;2(10):1266\u201381.","journal-title":"Cancer Res Commun"},{"issue":"4","key":"872_CR33","doi-asserted-by":"publisher","first-page":"283","DOI":"10.5114\/pjp.2021.114174","volume":"72","author":"Z Wang","year":"2021","unstructured":"Wang Z, Liang X, Wang X, Yu Q. Elevated expression of IGFL1 indicates unfavorable prognosis in lung adenocarcinoma through promotion of cell proliferation and inhibition of apoptosis. Pol J Pathol. 2021;72(4):283\u201395.","journal-title":"Pol J Pathol"},{"issue":"21","key":"872_CR34","doi-asserted-by":"publisher","first-page":"18969","DOI":"10.1074\/jbc.M111.224626","volume":"286","author":"AA Lobito","year":"2011","unstructured":"Lobito AA, Ramani SR, Tom I, Bazan JF, Luis E, Fairbrother WJ, et al. Murine insulin growth factor-like (IGFL) and human IGFL1 proteins are induced in inflammatory skin conditions and bind to a novel tumor necrosis factor receptor family member, IGFLR1. J Biol Chem. 2011;286(21):18969\u201381.","journal-title":"J Biol Chem"},{"key":"872_CR35","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.canlet.2021.04.016","volume":"515","author":"H Wang","year":"2021","unstructured":"Wang H, Shi Y, Chen CH, Wen Y, Zhou Z, Yang C, et al. KLF5-induced lncRNA IGFL2-AS1 promotes basal-like breast cancer cell growth and survival by upregulating the expression of IGFL1. Cancer Lett. 2021;515:49\u201362.","journal-title":"Cancer Lett"},{"issue":"9","key":"872_CR36","doi-asserted-by":"publisher","first-page":"8482","DOI":"10.1074\/jbc.M409197200","volume":"280","author":"A Lux","year":"2005","unstructured":"Lux A, Beil C, Majety M, Barron S, Gallione CJ, Kuhn HM, et al. Human retroviral gag- and gag-pol-like proteins interact with the transforming growth factor-beta receptor activin receptor-like kinase 1. J Biol Chem. 2005;280(9):8482\u201393.","journal-title":"J Biol Chem"},{"issue":"1","key":"872_CR37","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1186\/s13046-023-02903-x","volume":"42","author":"NB Katuwal","year":"2023","unstructured":"Katuwal NB, Kang MS, Ghosh M, Hong SD, Jeong YG, Park SM, et al. Targeting PEG10 as a novel therapeutic approach to overcome CDK4\/6 inhibitor resistance in breast cancer. J Exp Clin Cancer Res. 2023;42(1):325.","journal-title":"J Exp Clin Cancer Res"},{"issue":"9","key":"872_CR38","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1007\/s00018-022-04488-8","volume":"79","author":"V T\u00f3th","year":"2022","unstructured":"T\u00f3th V, Vad\u00e1szi H, Ravasz L, Mittli D, M\u00e1ty\u00e1s D, Moln\u00e1r T, et al. Neuronal-specific septin-3 binds Atg8\/LC3B, accumulates and localizes to autophagosomes during induced autophagy. Cell Mol Life Sci. 2022;79(9):471.","journal-title":"Cell Mol Life Sci"},{"key":"872_CR39","doi-asserted-by":"publisher","first-page":"e19359","DOI":"10.7717\/peerj.19359","volume":"13","author":"Q Shao","year":"2025","unstructured":"Shao Q, Gao HY, Wang ZY, Qian YL, Chen WX. Construction of a novel five programmed cell death-related gene signature as a promising prognostic model for triple negative breast cancer. PeerJ. 2025;13:e19359.","journal-title":"PeerJ"},{"key":"872_CR40","doi-asserted-by":"publisher","first-page":"4155","DOI":"10.2147\/IJGM.S419827","volume":"16","author":"GZ Wang","year":"2023","unstructured":"Wang GZ, Yang LH, Gao C. SEPTIN3 Promotes Progression of Triple-Negative Breast Cancer via Activating Wnt Pathway. Int J Gen Med. 2023;16:4155\u201364.","journal-title":"Int J Gen Med"},{"issue":"1","key":"872_CR41","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1186\/s12885-019-5803-1","volume":"19","author":"M Amrutkar","year":"2019","unstructured":"Amrutkar M, Aasrum M, Verbeke CS, Gladhaug IP. Secretion of fibronectin by human pancreatic stellate cells promotes chemoresistance to gemcitabine in pancreatic cancer cells. BMC Cancer. 2019;19(1):596.","journal-title":"BMC Cancer"},{"issue":"10","key":"872_CR42","doi-asserted-by":"publisher","first-page":"BSR20211615","DOI":"10.1042\/BSR20211615","volume":"41","author":"L Zhang","year":"2021","unstructured":"Zhang L, Wang L, Yang H, Li C, Fang C. Identification of potential genes related to breast cancer brain metastasis in breast cancer patients. Biosci Rep. 2021;41(10):BSR20211615.","journal-title":"Biosci Rep"},{"issue":"1","key":"872_CR43","doi-asserted-by":"publisher","first-page":"100336","DOI":"10.1016\/j.esmoop.2021.100336","volume":"7","author":"M Palmeri","year":"2022","unstructured":"Palmeri M, Mehnert J, Silk AW, Jabbour SK, Ganesan S, Popli P, et al. Real-world application of tumor mutational burden-high (TMB-high) and microsatellite instability (MSI) confirms their utility as immunotherapy biomarkers. ESMO Open. 2022;7(1):100336.","journal-title":"ESMO Open"},{"key":"872_CR44","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1007\/978-3-031-97242-3_5","volume":"129","author":"F Teymouri","year":"2025","unstructured":"Teymouri F, Brar G. Colorectal Cancers and Immunotherapy. Cancer Treat Res. 2025;129:83\u2013102.","journal-title":"Cancer Treat Res"},{"issue":"8","key":"872_CR45","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1158\/1078-0432.CCR-21-1935","volume":"30","author":"HC Wilbur","year":"2024","unstructured":"Wilbur HC, Le DT, Agarwal P. Immunotherapy of MSI Cancer: Facts and Hopes. Clin Cancer Res. 2024;30(8):1438\u201347.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"872_CR46","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta TM, Sokolov A, Gentles AJ, Burzykowski T, Poisson L, Weinstein JN, et al. Machine Learning Identifies Stemness Features Associated with Oncogenic Dedifferentiation. Cell. 2018;173(2):338\u201354.","journal-title":"Cell"}],"container-title":["Biology Direct"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13062-026-00872-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00872-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13062-026-00872-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:49:22Z","timestamp":1788482962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13062-026-00872-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,17]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["872"],"URL":"https:\/\/doi.org\/10.1186\/s13062-026-00872-7","relation":{},"ISSN":["1745-6150"],"issn-type":[{"value":"1745-6150","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,17]]},"assertion":[{"value":"28 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"N\/A.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not commissioned, externally peer-reviewed.The authors declare no potential conflicts of interest.","order":2,"name":"Ethics","label":"Provenance and peer review","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"164"}}